Roivant Sciences Ltd (ROIV)

11.84 -0.04 (-0.34%) USD  |  NASDAQ  |  Dec 13, 16:00
11.72 -0.12 (-1.01%) After-Hours: 20:00
More

Roivant Sciences Debt to Equity Ratio: 0.00 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for ROIV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Organon & Co 17.75
AstraZeneca PLC 0.7402
Adaptimmune Therapeutics PLC 0.6234
Biodexa Pharmaceuticals PLC --
Verona Pharma PLC 0.9197

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 6.206B
Total Liabilities (Quarterly) 625.99M
Shareholders Equity (Quarterly) 5.153B
Current Ratio 10.43
Net Debt Paydown Yield 1.02%